WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10

Benzinga · 2d ago
WBB Securities analyst Karen Sterling upgrades Turn Therapeutics (NASDAQ:TTRX) from Sell to Hold and maintains the price target from $10 to $10.